A Randomized, Double-Blind, Triple-Dummy, Single-Dose, Four-Way Crossover Study to Determine the Relative Bioavailability, Pharmacodynamic Effects, and Safety of Equivalent Doses of Whole and Crushed ALO-01 Versus Morphine IR in Opioid Experienced, Non-Dependent Subjects.
Phase of Trial: Phase I/II
Latest Information Update: 13 Sep 2013
At a glance
- Drugs Morphine/naltrexone (Primary) ; Morphine
- Indications Pain
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Alpharma
- 18 Mar 2009 Results presented at the 110th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics, 2009.
- 29 Sep 2008 New trial record.